ENvue Medical, Inc. Common Stock

FEEDNASDAQUSD
1.16 USD
0.09 (7.20%)AT CLOSE (11:59 AM EDT)
1.17
0.01 (0.43%)
POST MARKET (AS OF 05:40 PM EDT)
Post Market
AS OF 05:40 PM EDT
1.17
0.01 (0.43%)
🟢Market: OPEN
Open?$1.23
High?$1.23
Low?$1.15
Prev. Close?$1.25
Volume?114.3K
Avg. Volume?5.5M
VWAP?$1.18
Rel. Volume?0.02x
Bid / Ask
Bid?$1.01 × 100
Ask?$1.34 × 100
Spread?$0.33
Midpoint?$1.18
Valuation & Ratios
Market Cap?4.6M
Shares Out?3.7M
Float?1.1M
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?0.14
EPS?-$4.70
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.09Adequate
Quick Ratio?0.74Weak
Cash Ratio?0.63Adequate
Debt/Equity?0.03Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.14CHEAP
P/S?
1.81CHEAP
P/FCF?
N/A
EV/EBITDA?
-0.1CHEAP
EV/Sales?
0.58CHEAP
Returns & Efficiency
ROE?
-51.9%WEAK
ROA?
-42.3%WEAK
Cash Flow & Enterprise
FCF?$-9432000
Enterprise Value?$1.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
Employees
14
Market Cap
4.6M
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2015-04-24
Address
969 PRUITT AVE,
TYLER, TX 77569
Phone: (914) 233-3004